Brief: Jupiter Wellness Says Co's JW-100 Enters Clinical Trial For The Treatment Of Herpes
Nov 17 (Reuters) - Jupiter Wellness Inc JUPW.O :
* JUPITER WELLNESS’ JW-100 ENTERS CLINICAL TRIAL FOR THE
TREATMENT
OF HERPES
* JUPITER WELLNESS- INITIATED EXPLORATORY CLINICAL STUDY IN
TREATMENT OF HERPES LABIALIS (COLD SORES) FOR PRESCRIPTION
TOPICAL CREAM CANDIDATE JW-100
* JUPITER WELLNESS INC - STUDY DATA TO BE USED IN PLANNED
IND
FILING WITH U.S. FDA
Source text for Eikon: [ID:https://bit.ly/32T8iRt]
Further company coverage: JUPW.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bonk
See all newsBrief: Bonk Inc May Offer Up To $100 Million In Common Stock, Preferred Stock, Warrants, Rights, And Units - SEC Filing
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT REASON NOT AVAILABLE AT 03:58 AM
Brief: Bonk, Inc. Reports Q3 Financial Results Emerges Debt-Free With $9 Million In Cash And 1,200% Revenue Growth
Brief: Safety Shot Changes Name To Bonk Inc